A recent study has shown that the ferroptosis suppressor protein 1 (FSP1) inhibitor icFSP1 increases the level of cellular ferroptosis by driving the phase separation of FSP1, leading to an increased susceptibility of cancer cells to ferroptosis sensitization [6]. The gene discussed is AIFM2; the disease is cancer.